Grannus Therapeutics

Indianapolis, IN · Founded 2020 · Privately Held (backing)

Operator of a pre-clinical stage biotechnology company intended to support a cancer treatment. Grannus Therapeutics is based in Indianapolis, IN and was founded in 2020. It was valued at $5 million at its seed round in Jan 2022, the last priced event on record. It has raised $2.9 million across 2 recorded rounds; the latest was an $800,000 debt round in Nov 2023.

PMV mark · valuation
$5.0M
Oct 2026
Priced at
its seed round
Jan 2022
Total raised
$2.9M
Last round
Debt
Nov 2023
How much has Grannus Therapeutics raised?
$2.9Macross 2 recorded rounds · Jan 2022 – Nov 2023

Most recently, Grannus Therapeutics raised $800K in its Debt (Nov 2023).

Free account
More of Grannus Therapeutics with a free account
  • ·Watch Grannus Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Grannus Therapeutics round by round

2 rounds
Nov 2023Debt$800KSEC filing▮
9 investors participated
Jan 2022Seed Round$950KSEC filing▮
11 investors participated

How much has Grannus Therapeutics raised?

Grannus Therapeutics has raised $2.9 million in total; 2 of its rounds are on record. The largest on record was a $950,000 seed round in Jan 2022; the most recent was an $800,000 debt round in Nov 2023.

Grannus Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently in Jan 2024 ($800,000 sold to 9 investors).

Grannus Therapeutics investors

7 investors are on record for Grannus Therapeutics, including Plug and Play Tech Center, Elevate Ventures, 1842 Fund and Economic Development Corporation. The debt round in Nov 2023 drew 9 investors.

For fundraisers
Raising for a company like Grannus Therapeutics?

7 investors have backed Grannus Therapeutics.

See all 7 investors →

Frequently asked about Grannus Therapeutics

How much has Grannus Therapeutics raised?
Grannus Therapeutics has raised $2.9M in total across 2 recorded funding rounds.
When was Grannus Therapeutics's last funding round?
Grannus Therapeutics's most recent recorded round was Debt in Nov 2023, raising $800K.